Psychosocial stressors of drug-abusing disadvantaged adolescent mothers.
Scafidi, Frank A. ; Field, Tiffany ; Prodromidis, Margarita 等
Adolescence is a time of physical, psychological, and social change
and generally is considered a stressful period during normal
development. Additional psychosocial stressors such as pregnancy may
predispose some adolescents to poorer functioning (Ensminger, 1990). In
fact, adolescent pregnancy has been associated with increased depression
and lower self-esteem (Bolton, 1980), more disadvantaged socioeconomic
backgrounds (Barnett, Papini, & Gbur, 1991), and poorer family
communication (Lewis, 1978; Shah, Zelnik, & Kantner, 1975). The
constellation of psychosocial problems facing the adolescent mother also
places her at risk for illicit drug use. For example, disadvantaged
socio-economic backgrounds frequently are associated with increased drug
use, and adolescent girls have been noted to self-medicare for
depression. Peer and family systems also play an important role in the
onset of drug use. For example, the strongest single predictor of
current and future drug use is whether an adolescent's friends use
drugs. Similarly, familial use and their attitudes toward drugs and
alcohol are highly correlated with adolescent drug use. Adolescents
living in dysfunctional family systems including poor family cohesion,
negative communication patterns, unrealistic parental expectations, and
parental disengagement are at increased risk for drug use (Andrews et
al., 1991; Friedman & Utada, 1992; Swadi, 1992; Wills, Vacarro,
& McNamara, 1992). Poor academic achievement, poor sense of
competence, low self-concept, and nonconforming behaviors such as sexual
activity and rebelliousness also have been associated with early drug
use (Andrews et al., 1991).
Prevention and intervention programs for drug abuse could benefit
from evaluations of potential psychosocial stressors in many aspects of
the adolescent's life. Since poor mental health, dysfunctional
family and peer relationships, poor social skills, low educational and
vocational achievement, and inappropriate use of leisure time have been
related to early drug use (Andrews et al., 1991; Swadi, 1992; Willis et
al., 1992), it is important that these potentially problematic areas be
evaluated.
The present study attempted to identify the psychosocial stressors
associated with adolescent pregnancy and drug abuse. The sample
consisted of economically disadvantaged adolescent mothers classified as
drug abusing and nondrug abusing during pregnancy. The primary question
was whether drug-abusing mothers experienced more psychosocial stressors
than did the nondrug-abusing mothers from the same low socioeconomic
background. A secondary question was whether there was a cluster of
psychosocial stressors that differentiated the two groups of young
mothers.
METHOD
Sample
The sample consisted of 104 adolescent mothers between 13 and 21
years of age (M = 18) who received their obstetrical care at a large
inner-city university hospital. The young women were primarily single,
African-American, and Hispanic, with a tenth grade education (see Table
1).
Table 1
BDI PBF and Sociodemographic Variables for Drug Abusing and
Non-Drug Abusing Adolescent Mothers
Variables Drug-using Non-drug-using
(N = 55) (N = 49)
Mean (sd) Mean (sd) p
BDI 14.0 (9.2) 6.0 (2.4) .001
PBF 6.8 (3.0) 5.8 (3.2) .15
Age 18.6 (1.9) 18.2 (2.1) .31
Education 10.3 (1.6) 10.6 (1.5) .29
Socioeconomic Status 4.4 (0.8) 4.4 (0.6) .64
Measures
In order to identify adolescents who abused drugs during pregnancy
the following measures were conducted:
Urine toxicology. A urine toxicology screen was conducted on all
adolescent mothers upon admission to labor and delivery. Specific
immunoassays (EMIT, Syva) were performed for cocaine metabolite
(benzoylecgonine), opiates, and marijuana. In addition, urine toxicology
screens were performed on the infants' urine as soon as possible
after delivery.
Drug/alcohol history. A maternal history of substance abuse and
medication usage was completed during the admission history and physical
examination by the labor and delivery staff as per hospital protocol. In
addition, a separate interview was subsequently conducted after delivery
by a trained research associate. Mothers were asked to identify
substances used immediately prior to or during each trimester of
pregnancy. The list included caffeine, nicotine, alcohol (e.g., beer,
wine, liquor), nonprescription medications used for nonindicated
reasons, prescription medications used in a nonprescribed manner (e.g.,
valium, codeine), and illicit drugs (e.g., marijuana, cocaine, heroin,
methadone). Mothers were asked to estimate the day they last used any of
the substances and the frequency of use (daily, weekly).
Inclusion criteria for the drug-abusing group included: a positive
toxicology screen for the mother or the infant or maternal reports of:
(a) 15 or more alcoholic drinks, (b) any marijuana use, or (c) any
cocaine use during pregnancy. Inclusion criteria for the nondrug-abusing
group included a negative toxicology screen and a history of not using
drugs; a history of less than 15 alcoholic drinks during pregnancy; or a
history of drug experimentation that occurred more than six months
before pregnancy).
Within 24 hours after delivery each mother was administered a social
history, the Beck Depression Inventory (BDI), the Paranoid-Borderline
Features Scale (PFB) adapted from the Millon Clinical Multiaxial
Inventory, and the Problem Oriented Screening Instrument for Teenagers
(POSIT). All scales were administered in an interview format to control
for differences in reading levels and were given in the order described
below.
Demographic data. This information was obtained by a brief interview
and included age, ethnicity, marital status, and education and
employment histories. Socioeconomic status was determined by the
Hollingshead two-factor index of social status.
Beck Depression Inventory. The revised Beck Depression Inventory
(Beck, Rush, Shaw, & Emery, 1979; Beck & Steer, 1987) is a
21-item self-report inventory that assesses a wide range of symptoms
associated with depression. The items reflect affective, cognitive,
motivational, and vegetative symptoms and are based on a 4-point scale
ranging from 0 to 3. The BDI is scored by summing the ratings on all the
items (scores can range from 0 to 63). Total scores above 13 are
indicative of depression. This instrument is applicable for use with
adolescents as young as 13 years (Steer & Beck, 1988).
Paranoid-Borderline Features (PBF). To determine the presence of
paranoid and borderline features, a subset of 15 questions from the
Millon Clinical Multiaxial Inventory (MCMI; Millon, 1982) were
administered. These questions reflect paranoid ideation, dependency, and
lack of trust, and require "true" or "false"
responses. A total score is obtained by summing the items (scores can
range from 0 to 15). Higher scores represent greater paranoid and
borderline characteristics.
Problem Oriented Screening Instrument for Teenagers. The POSIT is a
validated 139-item screening instrument developed by the National
Institute of Drug Abuse (Rahdert, 1991) to aid in the identification of
adolescent problem behaviors. This questionnaire utilizes a yes/no
response format and identifies social, familial, educational, physical,
and psychological stressors in ten functional areas: Substance
Use/Abuse, Mental Health, Physical Health, Family Relations, Peer
Relations, Educational Status, Vocational Status, Social Skills, Leisure
and Recreation, and Aggressive Behavior/Delinquency which was used to
screen for social, emotional and behavioral problems. A total adjusted
mean score is calculated on each of the 10 problem or potentially
stressful areas represented on the POSIT questionnaire. The POSIT is a
good measure for differentiating adolescents with and those without
known problems (Rahdert, 1991; Babor et al., 1991).
RESULTS
No significant differences were noted between the groups (drug versus
nondrug) on any of the sociodemographic variables except on the BDI (see
Table 1). Drug-abusing mothers were more depressed than nondrug-abusing
mothers (t (102) = 6.18, p [less than] .001).
Drug-abusing mothers received higher (less optimal) Total scores on
the POSIT than nondrug-abusing mothers (t (94) = 7.29, p [less than]
.001). In addition, drug-abusing mothers obtained higher adjusted total
scores on every scale: Substance Use/Abuse (t (102) = 3.92, p [less
than] .001); Physical Health (t (102) = 2.40, p [less than] .02); Mental
Health (t (192) = 6.67, p [less than] .001); Family Relations (t (102) =
5.39, p [less than] .001); Peer Relations (t (102) = 6.07, p [less than]
.001); Educational Status (t (102) = 6.76, p [less than] .001);
Vocational Status (t (102) = 3.41, p [less than] .001); Social Skills (t
(102) = 5.29, p [less than] .001); Leisure/Recreation (t (102) = 3.96, p
[less than] .001); and Aggressive Behavior (t (102) = 4.66, p [less
than] .001).
A stepwise multiple regression analysis was performed to determine
the relative contribution of each POSIT subscale to adolescent mother
drug abuse. The regression analysis yielded a three-variable model that
accounted for 40% of the variance and included Mental Health (30%),
Leisure and Recreation (6%) and Peer Relationships (5%).
Table 2
Means and Standard Deviations for Drug Abusing and Non-Drug
Abusing Adolescent Mothers on Adjusted Total Subscale Scores of
the POSIT
Measures(1) Drug-using Nondrug
(N = 55) (N = 49)
Mean (sd) Mean (sd) p
POSIT Total score 50.84 (17.8) 28.60 (11.6) .001
Substance Use 0.10 (0.2) 0.00 (0.0) .001
Physical Health 0.40 (0.2) 0.32 (0.1) .01
Mental Health 0.41 (0.2) 0.18 (0.2) .001
Family Relations 0.32 (0.2) 0.11 (0.1) .001
Peer Relations 0.39 (0.2) 0.19 (0.2) .001
Educational Status 0.38 (0.1) 0.20 (0.1) .001
Vocational Status 0.34 (0.1) 0.14 (0.2) .001
Social Skills 0.36 (0.1) 0.20 (0.1) .001
Leisure and Recreation 0.48 (0.2) 0.35 (0.2) .001
Aggressive Behavior 0.33 (0.2) 0.18 (0.2) .001
1 Lower scores are optimal
A discriminant function analysis was then conducted to determine how
well the POSIT scales classified drug-abusing and nondrug-abusing
mothers. The discriminant function consisting of Mental Health, Leisure
and Recreation, Peer Relationships, Physical Health and Social Skills,
respectively, correctly classified 75% of the drug-abusing mothers and
84% of the nondrug-abusing mothers (Lambda (102) = .55, p [less than]
.0001). The function loaded most heavily on the Mental Health subscale.
DISCUSSION
In the present study drug-abusing adolescent mothers experienced more
psychosocial stressors than did nondrug-abusing mothers, suggesting
several factors that might lead to, maintain, or be the consequence of
drug abuse. Studies of adolescents have associated several factors with
early drug use including peer pressure, a dysfunctional family system,
poor academic achievement, and low self-esteem (Friedman & Utanda,
1992; Wills et al., 1992). The findings from this study suggest that
similar factors are predictive of drug abuse during adolescent
pregnancy. Targeting this specific population is important since
previous research has demonstrated that the adolescent mother is at risk
for poorer psychosocial functioning (Ensminger, 1990; Prodromidis et
al., 1993).
Drug-abusing adolescent mothers reported poorer physical and mental
health, lower vocational and educational status, more family and peer
relations problems, less constructive use of leisure time, poorer social
skills, and more aggressive behavior than did nondrug-abusing adolescent
mothers. Mental Health was the most important factor associated with
drug abuse in adolescent mothers. This finding is not surprising since
the BDI indicated that drug-abusing adolescent mothers were more likely
to be depressed than were the nondrug-abusing mothers. Further,
depressed adolescent girls are known to self-medicate for depression
(Adams & Adams, 1991). A recent study noted that 14% of adolescents
attending a family planning clinic reported using drugs. Infants exposed
to drugs in utero are at greater risk for developmental problems
including low birthweight, smaller head circumference, increased
irritability, motor deficits, and long-term neurological sequalae
(Chasnoff, Lewis, Griffith, & Wiley, 1989; Eisen et al., 1991;
Scafidi et al., 1996; Young, Vosper, & Phillips, 1992).
Identification of specific problem areas is essential for developing
additional assessment strategies and individualized intervention plans
for preventing drug abuse in pregnant adolescents. The POSIT, a
comprehensive screening instrument designed to evaluate potential
problem areas for the teenager, is a useful screening instrument both
for identifying problem areas and identifying pregnant adolescents who
are at risk for drug abuse.
REFERENCES
Adams, M., & Adams, J. (1991). Life events, depression, and
perceived problem-solving alternatives in adolescents. Journal of Child
Psychology and Psychiatry and Allied Disciplines, 32, 811-820.
Andrews, J. A., Hops, H., Ary, D., Lichtenstein, E., & Tildesley,
S. (1991). The construction, validation and use of a Guttman scale of
adolescent substance use: An investigation of family relationships.
Journal of Drug Issues, 21, 557-572.
Babor, T. F., DelBoca, F., McLaney, M. A., Jacobi, B.,
Higgins-Biddle, J., & Hass, W. (1991). Matching adolescents to
appropriate interventions for alcohol and other drug-related problems.
Alcohol Health and Research World, 5, 77-86.
Barnett, J. K., Papini, D. R., & Gbur, E. (1991). Familial
correlates of sexually active pregnant and nonpregnant adolescents.
Adolescence, 26, 457-472.
Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979).
Cognitive therapy of depression. New York: Guilford Press.
Beck, A. T., & Steer, R. A. (1987). Manual for the revised Beck
Depression Inventory. San Antonio, TX: Psychological Corporation.
Bolton, F. G. (1980). The pregnant adolescent: Problems of premature
parenthood. Beverly Hills, CA: Sage.
Chasnoff, I. J., Lewis, D. E., Griffith, D. R., & Wiley, S.
(1989). Cocaine and pregnancy: Clinical and toxicological implications
for the neonate. Clinical Chemistry, 35, 1276-1278.
Eisen, L. N., Field, T. M., Bandstra, E. S., Roberts, J. P., Morrow,
C., & Larson, S. K. (1991). Perinatal cocaine effects on neonatal
stress behavior and performance on the Brazelton Scale. Pediatrics, 88,
477-480.
Ensminger, M. E. (1990). Sexual activity and problem behaviors among
black, urban adolescents. Child Development, 61, 2032-2046.
Friedman, A. S., & Utada, A. T. (1992). Effects of two group
interaction models on substance-using adjudicated adolescent males.
Journal of Community Psychology, 20, 349-374.
Lewis, R. A. (1978). Parents and peers: Socialization agents in the
social behavior of young adults. Journal of Sex Research, 9, 156-170.
Millon, T. (1982). Millon Clinical Multiaxial Inventory Manual.
Minneapolis: National Computer Systems.
Prodromidis, M., Abrams, S., Field, T., Scafidid, F., & Rahdert,
E. (in press). Psychosocial stressors of depressed adolescent mothers.
Rahdert, E. (1991). Adolescent Assessment/Referral System Manual,
U.S. Department of Health and Human Services, Publication No. (ADM)
91-1735.
Scafidi, F. A., Field, T., Wheeden, A., Schanberg, S., Kuhn, C.,
Symanski, R., Zimmerman, E., & Bandstra, E. (1996). Cocaine-exposed
preterm neonates show behavioral and hormonal differences.
Shah, F., Zelnik, M., & Kantner, J. F. (1975). Unprotected
intercourse among unwed teenagers. Family Planning Perspectives, 1,
39-44.
Steer, R. A., & Beck, T. T. (1988) . Use of the Beck Depression
Inventory, Hopelessness Scale, Scale for Suicide Ideation, and Suicidal
Intent Scale with adolescents. In A. R. Stiffman, & R. A. Feldman
(Eds.), Advances in adolescent mental health (pp. 219-231). Greenwich,
CT: JAI Press.
Swadi, H. (1992). Relative risk factors in detecting adolescent drug
use. Drug and Alcohol Dependence, 29, 253-254.
Wills, T. A., Vaccaro, D., & McNamara, G. (1992). The role of
life events, family support, and competence in adolescent substance use.
A test of vulnerability and protective factors. American Journal of
Community Psychology, 20, 349-374.
Young, S. L., Vosper, H. J., & Phillips, S. A. (1992). Cocaine:
Its effects on maternal and child health. Pharmacotherapy, 12, 2-17.
Frank Scafidi, Ph.D., Assistant Research Professor, Touch Research
Institute, University of Miami School of Medicine.
Margarita Prodromidis, Ph.D., Research Associate, Touch Research
Institute, University of Miami School of Medicine.
Elizabeth Rahdert, Ph.D., Project Officer, National Institute on Drug
Abuse.